Dihydropyridine receptor (DHPR, CACNA1S) congenital myopathy - Archive ouverte HAL
Journal Articles Acta Neuropathologica Year : 2017

Dihydropyridine receptor (DHPR, CACNA1S) congenital myopathy

Norma Romero
  • Function : Author
Sandra Donkervoort
Susan Treves
  • Function : Author
Pinki Munot
  • Function : Author
Tyler Pierson
  • Function : Author
Ivana Dabaj
  • Function : Author
Edoardo Malfatti
  • Function : Author
Irina Zaharieva
  • Function : Author
Francesco Zorzato
  • Function : Author
Osario Abath Neto
  • Function : Author
Guy Brochier
  • Function : Author
Bruno Eymard
Ana Taratuto
  • Function : Author
Hernan Gonorazky
  • Function : Author
Leigh Ramos-Platt
  • Function : Author
Lucy Feng
  • Function : Author
Rahul Phadke
  • Function : Author
Diana Bharucha-Goebel
  • Function : Author
Charlotte Sumner
  • Function : Author
Mai Bui
  • Function : Author
Emmanuelle Lacene
  • Function : Author
Maud Beuvin
Clémence Labasse
  • Function : Author
Nicolas Dondaine
  • Function : Author
Raphael Schneider
Anne Boland
Jean-François Deleuze
Emma Matthews
Aleksandra Pakleza
  • Function : Author
Caroline Sewry
  • Function : Author
Susana Quijano-Roy
  • Function : Author
Francesco Muntoni
Michel Fardeau
  • Function : Author
Carsten Bönnemann
  • Function : Author

Abstract

Muscle contraction upon nerve stimulation relies on excitation-contraction coupling (ECC) to promote the rapid and generalized release of calcium within myofibers. In skeletal muscle, ECC is performed by the direct coupling of a voltage-gated L-type Ca2+ channel (dihydropyridine receptor; DHPR) located on the T-tubule with a Ca2+ release channel (ryanodine receptor; RYR1) on the sarcoplasmic reticulum (SR) component of the triad. Here, we characterize a novel class of congenital myopathy at the morphological, molecular, and functional levels. We describe a cohort of 11 patients from 7 families presenting with perinatal hypotonia, severe axial and generalized weakness. Ophthalmoplegia is present in four patients. The analysis of muscle biopsies demonstrated a characteristic intermyofibrillar network due to SR dilatation, internal nuclei, and areas of myofibrillar disorganization in some samples. Exome sequencing revealed ten recessive or dominant mutations in CACNA1S (Cav1.1), the pore-forming subunit of DHPR in skeletal muscle. Both recessive and dominant mutations correlated with a consistent phenotype, a decrease in protein level, and with a major impairment of Ca2+ release induced by depolarization in cultured myotubes. While dominant CACNA1S mutations were previously linked to malignant hyperthermia susceptibility or hypokalemic periodic paralysis, our findings strengthen the importance of DHPR for perinatal muscle function in human. These data also highlight CACNA1S and ECC as therapeutic targets for the development of treatments that may be facilitated by the previous knowledge accumulated on DHPR.

Dates and versions

hal-03676425 , version 1 (23-05-2022)

Identifiers

Cite

Vanessa Schartner, Norma Romero, Sandra Donkervoort, Susan Treves, Pinki Munot, et al.. Dihydropyridine receptor (DHPR, CACNA1S) congenital myopathy. Acta Neuropathologica, 2017, 133 (4), pp.517-533. ⟨10.1007/s00401-016-1656-8⟩. ⟨hal-03676425⟩
64 View
0 Download

Altmetric

Share

More